
The production of insulin1 is among the gene2 technology applications with potential long-term public health benefits.
Insulin is produced using recombinant gene technology and it is approved for use in New Zealand.
The production of insulin1 is among the gene2 technology applications with potential long-term public health benefits.
Insulin is produced using recombinant gene technology and it is approved for use in New Zealand.